» Articles » PMID: 22276281

Rheumatic Fever - Identification, Management and Secondary Prevention

Overview
Specialty Public Health
Date 2012 Jan 26
PMID 22276281
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute rheumatic fever is a rare multisystem disease caused by an immunological response to Group A streptococcus infection. Acute rheumatic fever usually has onset in childhood and is most prevalent in Aboriginal and Maori populations and other disadvantaged groups.

Objective: In this article we outline the clinical features of acute rheumatic fever and describe the important role of primary healthcare providers in its identification, management and secondary prevention.

Discussion: Recurrent episodes of acute rheumatic fever may lead to rheumatic heart disease. Early detection of acute rheumatic fever and provision of secondary prophylaxis with antibiotics is paramount to the prevention of rheumatic heart disease. Primary healthcare providers can play an important role in identifying acute rheumatic fever and ensuring adherence to treatment within the context of a complex interplay of cultural and socioeconomic factors. The recent establishment of RHD Australia will support the development of appropriate educational resources and their dissemination among health professionals and vulnerable communities.

Citing Articles

Recent Scientific Advancements towards a Vaccine against Group A .

Fan J, Toth I, Stephenson R Vaccines (Basel). 2024; 12(3).

PMID: 38543906 PMC: 10974072. DOI: 10.3390/vaccines12030272.


A Review of : Public Health Risk Factors, Prevention and Control.

Avire N, Whiley H, Ross K Pathogens. 2021; 10(2).

PMID: 33671684 PMC: 7926438. DOI: 10.3390/pathogens10020248.


Efficacy of an incentive intervention on secondary prophylaxis for young people with rheumatic fever: a multiple baseline study.

Oetzel J, Lao C, Morley M, Penman K, Child M, Scott N BMC Public Health. 2019; 19(1):385.

PMID: 30953495 PMC: 6451207. DOI: 10.1186/s12889-019-6695-3.


Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14-21 in New Zealand: a framework method study.

Barker H, Oetzel J, Scott N, Morley M, Atatoa Carr P, Oetzel K Int J Equity Health. 2017; 16(1):201.

PMID: 29149897 PMC: 5693496. DOI: 10.1186/s12939-017-0700-1.


Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network.

Lau J, Kiss C, Roberts E, Horne K, Korman T, Woolley I Ann Clin Microbiol Antimicrob. 2017; 16(1):3.

PMID: 28100229 PMC: 5241934. DOI: 10.1186/s12941-017-0180-6.